Priming of the antitumor response promotes efficacy of interleukin-2therapy

L.A. Everse; M.R. Bernsen; H.F.J. Dullens; W. den Otter

Priming of the antitumor response promotes efficacy of interleukin-2therapy

Translated title of the contribution: Priming of the antitumor response promotes efficacy of interleukin-2therapy

L.A. Everse, M.R. Bernsen, H.F.J. Dullens, W. den Otter

Department of Pathology

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Priming of the antitumor response promotes efficacy of interleukin-2therapy
Original language	Undefined/Unknown
Pages (from-to)	221-229
Number of pages	9
Journal	Cancer Immunology, Immunotherapy
Volume	44
Publication status	Published - 1997

Keywords

Econometric and Statistical Methods: General
Medical technology
Farmacie(FARM)
Geneeskunde(GENK)
Bescherming en bevordering van de menselijke gezondheid
Biomedische technologie en medicijnen
Immunology
Pharmacology

Cite this

@article{039e1f8f2a424af2b10168e3e96c25d7,

title = "Priming of the antitumor response promotes efficacy of interleukin-2therapy",

keywords = "Econometric and Statistical Methods: General, Medical technology, Farmacie(FARM), Geneeskunde(GENK), Bescherming en bevordering van de menselijke gezondheid, Biomedische technologie en medicijnen, Immunology, Pharmacology",

author = "L.A. Everse and M.R. Bernsen and H.F.J. Dullens and {den Otter}, W.",

year = "1997",

language = "Undefined/Unknown",

volume = "44",

pages = "221--229",

journal = "Cancer Immunology, Immunotherapy",

issn = "0340-7004",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - Priming of the antitumor response promotes efficacy of interleukin-2therapy

AU - Everse, L.A.

AU - Bernsen, M.R.

AU - Dullens, H.F.J.

AU - den Otter, W.

PY - 1997

Y1 - 1997

KW - Econometric and Statistical Methods: General

KW - Medical technology

KW - Farmacie(FARM)

KW - Geneeskunde(GENK)

KW - Bescherming en bevordering van de menselijke gezondheid

KW - Biomedische technologie en medicijnen

KW - Immunology

KW - Pharmacology

M3 - Article

SN - 0340-7004

VL - 44

SP - 221

EP - 229

JO - Cancer Immunology, Immunotherapy

JF - Cancer Immunology, Immunotherapy

ER -